SPI
IART icon

Santori & Peters Inc’s Integra LifeSciences IART Stock Holding History

Santori & Peters Inc’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-110
Closed -$5K – 274
2017
Q4 		$5K Buy
+110
New +$5.38K ﹤0.01% 432

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Santori & Peters Inc's IART Position: Q1 2018 in Review

Santori & Peters Inc sold out of Integra LifeSciences (IART) in Q1 2018, closing a stake of 110 shares — an estimated $5K sold.

Santori & Peters Inc first reported a position in IART in Q4 2017 and held it in 1 quarter. The position peaked at $5K in Q4 2017. 235 funds tracked by Wall St. Rank hold IART as of Q1 2018.

  • Santori & Peters Inc reported no remaining Integra LifeSciences position as of Q1 2018 after selling out during the quarter.
  • Santori & Peters Inc sold 110 Integra LifeSciences shares in Q1 2018, an estimated $5K.
  • Santori & Peters Inc first reported a position in Integra LifeSciences in Q4 2017 and held it in 1 quarter.
  • Santori & Peters Inc's Integra LifeSciences position peaked at $5K in Q4 2017.
  • 235 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2018.

Based on Santori & Peters Inc's 13F filing for Q1 2018, filed 16 Apr 2018.